
Daniel F. Coughlin
Examiner (ID: 5114, Phone: (571)270-3748 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 626 |
| Issued Applications | 242 |
| Pending Applications | 84 |
| Abandoned Applications | 330 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8845804
[patent_doc_number] => 08454980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Hydrogel bioscaffold and coating for bone and tooth repair'
[patent_app_type] => utility
[patent_app_number] => 13/359209
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6521
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359209 | Hydrogel bioscaffold and coating for bone and tooth repair | Jan 25, 2012 | Issued |
Array
(
[id] => 9462864
[patent_doc_number] => 20140127291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'EXTENDED RELEASE ACETAMINOPHEN LIQUID PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/982179
[patent_app_country] => US
[patent_app_date] => 2012-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982179 | EXTENDED RELEASE ACETAMINOPHEN LIQUID PHARMACEUTICAL COMPOSITIONS | Jan 24, 2012 | Abandoned |
Array
(
[id] => 9319743
[patent_doc_number] => 20140052081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'DONEPEZIL TRANSDERMAL PATCH'
[patent_app_type] => utility
[patent_app_number] => 13/979579
[patent_app_country] => US
[patent_app_date] => 2012-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3560
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979579 | DONEPEZIL TRANSDERMAL PATCH | Jan 11, 2012 | Abandoned |
Array
(
[id] => 11886808
[patent_doc_number] => 09757355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide'
[patent_app_type] => utility
[patent_app_number] => 13/978869
[patent_app_country] => US
[patent_app_date] => 2012-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12588
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978869 | Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide | Jan 8, 2012 | Issued |
Array
(
[id] => 8177671
[patent_doc_number] => 20120110957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/343879
[patent_app_country] => US
[patent_app_date] => 2012-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7396
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20120110957.pdf
[firstpage_image] =>[orig_patent_app_number] => 13343879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/343879 | METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATION | Jan 4, 2012 | Abandoned |
Array
(
[id] => 9338447
[patent_doc_number] => 20140065229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'HYDROPHOBIC AND HYDROPHYLIC AEROGELS ENCAPSULATED WITH PEG HYDROGEL VIA SURFACE INITIATED PHOTOPOLYMERIZATION'
[patent_app_type] => utility
[patent_app_number] => 13/979019
[patent_app_country] => US
[patent_app_date] => 2012-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2941
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979019 | HYDROPHOBIC AND HYDROPHYLIC AEROGELS ENCAPSULATED WITH PEG HYDROGEL VIA SURFACE INITIATED PHOTOPOLYMERIZATION | Jan 4, 2012 | Abandoned |
Array
(
[id] => 9607712
[patent_doc_number] => 08784877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Transdermal levonorgestrel device and delivery'
[patent_app_type] => utility
[patent_app_number] => 13/337594
[patent_app_country] => US
[patent_app_date] => 2011-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7998
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13337594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/337594 | Transdermal levonorgestrel device and delivery | Dec 26, 2011 | Issued |
Array
(
[id] => 9068191
[patent_doc_number] => 20130259947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ORAL METRONIDAZOLE PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/990000
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12952
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990000
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/990000 | ORAL METRONIDAZOLE PHARMACEUTICAL COMPOSITIONS | Nov 28, 2011 | Abandoned |
Array
(
[id] => 9015609
[patent_doc_number] => 20130230573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'COLLAGEN STRUCTURES AND METHOD OF FABRICATING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/885690
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11630
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885690
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885690 | COLLAGEN STRUCTURES AND METHOD OF FABRICATING THE SAME | Nov 15, 2011 | Abandoned |
Array
(
[id] => 8977923
[patent_doc_number] => 20130211353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'PERCUTANEOUS ABSORPTION TYPE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/881829
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6651
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881829
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881829 | PERCUTANEOUS ABSORPTION TYPE FORMULATION | Oct 25, 2011 | Abandoned |
Array
(
[id] => 11886911
[patent_doc_number] => 09757459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Liquid pharmaceutical composition for the delivery of active ingredients'
[patent_app_type] => utility
[patent_app_number] => 13/824048
[patent_app_country] => US
[patent_app_date] => 2011-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824048
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/824048 | Liquid pharmaceutical composition for the delivery of active ingredients | Oct 17, 2011 | Issued |
Array
(
[id] => 8963075
[patent_doc_number] => 20130202677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'PATCH'
[patent_app_type] => utility
[patent_app_number] => 13/876259
[patent_app_country] => US
[patent_app_date] => 2011-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11084
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876259 | PATCH | Sep 29, 2011 | Abandoned |
Array
(
[id] => 8951255
[patent_doc_number] => 20130197036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'TRANSDERMAL ABSORPTION PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/877036
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6119
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877036 | TRANSDERMAL ABSORPTION PREPARATION | Sep 28, 2011 | Abandoned |
Array
(
[id] => 14142967
[patent_doc_number] => 10251834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Transdermal drug administration device
[patent_app_type] => utility
[patent_app_number] => 13/821039
[patent_app_country] => US
[patent_app_date] => 2011-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10369
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/821039 | Transdermal drug administration device | Sep 4, 2011 | Issued |
Array
(
[id] => 7760826
[patent_doc_number] => 20120031047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'METHOD FOR STORING TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION AND PACKAGE OF TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/196389
[patent_app_country] => US
[patent_app_date] => 2011-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5969
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20120031047.pdf
[firstpage_image] =>[orig_patent_app_number] => 13196389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/196389 | METHOD FOR STORING TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION AND PACKAGE OF TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION | Aug 1, 2011 | Abandoned |
Array
(
[id] => 7755451
[patent_doc_number] => 20120028204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'CORRECTION OF ALVEOLAR CLEFT WITH CALCIUM-BASED BONE GRAFT MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 13/195568
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2298
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028204.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195568 | CORRECTION OF ALVEOLAR CLEFT WITH CALCIUM-BASED BONE GRAFT MATERIALS | Jul 31, 2011 | Abandoned |
Array
(
[id] => 8208918
[patent_doc_number] => 20120128582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'METHODS AND COMPOSITIONS OF [32P]-LABELED ADENINE NUCLEOTIDES FOR THE TREATMENT OF ATHEROSCLEROSIS, VASCULAR ARTERIAL DISEASES AND CORONARY ARTERY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/185083
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3947
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128582.pdf
[firstpage_image] =>[orig_patent_app_number] => 13185083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/185083 | Methods and compositions of [32P]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases | Jul 17, 2011 | Issued |
Array
(
[id] => 7731699
[patent_doc_number] => 20120015017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Slow releasing microcapsules containing an active substance'
[patent_app_type] => utility
[patent_app_number] => 13/135409
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7798
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015017.pdf
[firstpage_image] =>[orig_patent_app_number] => 13135409
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/135409 | Slow releasing microcapsules containing an active substance | Jul 4, 2011 | Abandoned |
Array
(
[id] => 7506197
[patent_doc_number] => 20110253754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'AEROSOL PAINT COMPOSITION WITH FUNGICIDE AND SPRAYABLE AEROSOL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/175325
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2618
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20110253754.pdf
[firstpage_image] =>[orig_patent_app_number] => 13175325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/175325 | AEROSOL PAINT COMPOSITION WITH FUNGICIDE AND SPRAYABLE AEROSOL COMPOSITION | Jun 30, 2011 | Abandoned |
Array
(
[id] => 8824867
[patent_doc_number] => 20130125912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'NANOFIBER'
[patent_app_type] => utility
[patent_app_number] => 13/703315
[patent_app_country] => US
[patent_app_date] => 2011-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8267
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/703315 | NANOFIBER | Jun 27, 2011 | Abandoned |